Lupin Launches Generic Suprep® Bowel Prep Kit in the United States

Global pharma major Lupin Limited (Lupin) today announced the launch of Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate Oral Solution, 17.5 g/3.13 g/1.6 g per 6 ounces, having received an approval from the United States Food and Drug Administration (FDA).

Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate Oral Solution, 17.5 g/3.13 g/1.6 g per 6 ounces is a generic equivalent of Suprep® Bowel Prep Kit Oral Solution, 17.5 g/3.13 g/1.6 g per 6 ounces, of Braintree Laboratories Inc.

Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate Oral Solution (RLD Suprep® Bowel Prep Kit) had estimated annual sales of USD 202 million in the U.S. (IQVIA MAT July 2022).

Source : Equity Bulls

Keywords

Lupin SodiumSulfate PotassiumSulfate MagnesiumSulfate OralSolution USFDA Approval